<DOC>
	<DOC>NCT01146626</DOC>
	<brief_summary>Standard therapy for chronic hepatitis C virus (HCV) is (Peg/RBV) combination therapy obtaining sustained virologic response (SVR) in 80% of naïve patients with genotype 2,3. Studies rarely address the issues of improving host factors. The current study examines 1. whether adding vitamin D, a potent immunomodulator, could improve viral response and shorten treatment duration (from 24 weeks to 12 weeks) 2. whether Vitamin D levels predictes negative treatment outcome.</brief_summary>
	<brief_title>Does Vitamin D Improves Sustained Virologic Response (SVR) in Genotype 2,3 Chronic Hepatitis C Patients?</brief_title>
	<detailed_description>Standard therapy for chronic hepatitis C virus (HCV) is (Peg/RBV) combination therapy obtaining sustained virologic response (SVR) in 80% of naïve patients with genotype 2,3. Studies rarely address the issues of improving host factors. The current study examines whether adding vitamin D, a potent immunomodulator, could improve viral respons.The working hypothesis is that Adding vitamin D to conventional Peg/RBV therapy for naïve, genotype 2,3 patients with chronic HCV infection significantly improves RVR, EVR, and SVR</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis, Chronic</mesh_term>
	<mesh_term>Hepatitis C, Chronic</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>18 to 65 years of age, Chronic genotype 2,3 HCV infection, Traetment Naive Negative sero for HBV, HDV and HIV viral infections Absolute neutrophil count of &gt;1500 per cubic millimeter, a platelet count of &gt;90,000 per cubic millimeter Normal hemoglobin level Decompensated liver disease (cirrhosis with CP score &gt;9) Another cause of clinically significant liver disease Hepato cellular carcinoma Psychiatric Disorder Chronic heart failure Pregnant women Uncontrolled diabetes with retinopathy Arythmia Active CAD Positive sero for HBV, HDV and HIV viral infections or other autoimmune liver disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Vitamin D</keyword>
	<keyword>Hepatitis C</keyword>
	<keyword>Genotype2,3</keyword>
	<keyword>SVR</keyword>
	<keyword>Naive</keyword>
	<keyword>RVR rate</keyword>
	<keyword>EVR rate</keyword>
	<keyword>SVR rate</keyword>
</DOC>